Personalized dosing could improve lupus kidney treatment for kids
NCT ID NCT05538208
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways of dosing the drug mycophenolate mofetil (MMF) for children with lupus nephritis, a kidney disease caused by lupus. One method uses a standard dose based on body size, while the other adjusts the dose based on drug levels in the blood. The goal is to see if personalized dosing leads to better kidney remission after 26 weeks. About 105 children aged 8 to under 21 are being enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mycophenolate mofetil (MMF)
- What this could lead to
- If successful, this could provide a more effective way to control lupus nephritis in children, potentially reducing kidney damage and improving long-term outcomes.
- What could go wrong
- This is a Phase 2 trial with only 105 participants, so results may not apply to all patients. The personalized dosing approach may not prove superior to standard dosing, and MMF can have side effects like infection risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Akron Children's Hospital
RECRUITINGAkron, Ohio, 44307, United States
-
Ann & Robert H. Lurie Children's Hospital of Chicago
RECRUITINGChicago, Illinois, 60614, United States
-
Baylor College of Medicine Pediatric Immunology Allergy Rheumatology
RECRUITINGHouston, Texas, 77030, United States
-
Children's Hospital Colorado
RECRUITINGAurora, Colorado, 80045, United States
-
Children's Hospital at Montefiore
RECRUITINGNew York, New York, 10467, United States
-
Children's Wisconsin/Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45223, United States
-
Emory Children's Center
RECRUITINGAtlanta, Georgia, 30322, United States
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
-
Hospital for Special Surgery
RECRUITINGNew York, New York, 10021, United States
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
-
Nationwide Children's Hospital
RECRUITINGColumbus, Ohio, 43205, United States
-
Seattle Children's Hospital/University of Washington
RECRUITINGSeattle, Washington, 98105, United States
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94518, United States
-
University of Chicago Medicine- Comer Children's
RECRUITINGChicago, Illinois, 60637, United States
-
University of North Carolina at Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
University of Utah
RECRUITINGSalt Lake City, Utah, 84132, United States
-
Washington University in St. Louis School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test may reveal kidney damage in lupus — no biopsy needed?
- Can a Three-Drug combo quiet lupus kidney flares?
- Can a single infusion tame tough lupus?
- Can a smartphone app bridge the lupus care gap for women of color?
- Can a single drug calm lupus kidney disease without a cocktail of meds?
- Cancer drug shows promise for lupus kidney disease